| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 43.8% | 7/16 |
| Female | 56.3% | 9/16 |
| Indifferent | 0% | 0/16 |
| Unknown | 0% | 0/16 |
| General | ||
| 37.5% | 6/16 | |
| 31.3% | 5/16 | |
| 25% | 4/16 | |
| 25% | 4/16 | |
| 25% | 4/16 | |
| 31.3% | 5/16 | |
| 50% | 8/16 | |
| 62.5% | 10/16 | |
| 62.5% | 10/16 | |
| 42.9% | 3/7 | |
| Neurology | ||
| 37.5% | 6/16 | |
| 6.3% | 1/16 | |
| 75% | 12/16 | |
| Facial abnormalities | ||
| Abnormality of the ear | 0% | 0/16 |
| 43.8% | 7/16 | |
| 12.5% | 2/16 | |
| 93.8% | 15/16 | |
| Visual and hearing impairments | ||
| Abnormal hearing | 0% | 0/16 |
| 25% | 4/16 | |
| Heart | ||
| 25% | 4/16 | |
| Pulmonary | ||
| 12.5% | 2/16 | |
| Gastrointestinal | ||
| 50% | 8/16 | |
| Urogenital | ||
| 43.8% | 7/16 | |
| Skeleton | ||
| 93.8% | 15/16 | |
| Skin / Hair / Nails | ||
| Skin/Hair/Nails | 0% | 0/16 |
| Endocrine / Immunological / Metabolic | ||
| 6.3% | 1/16 | |
| 25% | 4/16 | |
| 18.8% | 3/16 | |
| Neoplasia | ||
| 6.3% | 1/16 | |
| Inheritance | ||
| 80% | 12/15 | |
ARCN1